KPC Pharmaceuticals Inc600422
▼ ネガティブ資本関連度
KPC Pharmaceuticals plans to sell shares of Leed Biotech, which may signal a need to raise cash or divest assets, potentially reducing its investment value.
資産への影響 1
その他
KPC Pharmaceuticals Inc昆薬集団は公告で、本業の強化と資産構造の最適化を図るため、南京維立志博生物科技の株式を集中競争売買や大口取引などを通じて最大244万3022株まで売却する方針を明らかにした。
KPC Pharmaceuticals IncKPC Pharmaceuticals plans to sell shares of Leed Biotech, which may signal a need to raise cash or divest assets, potentially reducing its investment value.